. As this disease was clearly not linked exclusively to homosexuality, the term acquired immune deficiency syndrome (AIDS) was adopted 2 . Following the description of AIDS in the US, the disease was described in homosexual men and in intravenous drug users throughout Europe, South Africa and Australia by the end of 1982 2 . Subsequently, in 1984, it was reported that heterosexual cases of AIDS were occurring in large numbers in West, Central and Eastern Africa, involving minimally the countries of Zaire, Uganda and Rwanda. The global distribution of cases and the occurrence of disease in identical risk groups in different countries suggested strongly that an infectious agent was responsible for the epidemic and, as blood-borne transmission was common, it was most likely to be a virus. Two distinct patterns of transmission were observed 3 : pattern 1 was that of a blood-borne agent which was transmitted in a similar manner to the hepatitis B virus, and was prevalent in homosexual men, i.v. drug users, their sexual partners, and in recipients of blood and blood products. Pattern 1 transmission was occurring throughout the western world, and had turned the US cases into a pandemic over a very short period. Pattern 2 transmission was more similar to a classical sexually transmitted disease, and approximately equal numbers of male and female cases were found; pattern 2 transmission predominated in the developing world, in particular in subSaharan Africa 3 . From early 1982 onwards, efforts to identify the causative agent intensified and, in May 1983, a group from the Institut Pasteur, Paris, reported the isolation and propagation of a T-lymphotropic retrovirus, lymphadenopathy associated virus, LAV, from the lymph node of a patient with persistent lymphadenopathy, a syndrome known to be associated with, and preceding the development of, AIDS 4 . This virus had been fully characterised by 1984, and formally termed the human immunodeficiency virus type 1 (HTV-1) in 1986. Serological assays for antibodies to HTV-1 were widely commercially available by 1985, allowing large-scale sero-epidemiology and screening to be undertaken. Examination of stored sera revealed that HTV-1 had been introduced into homosexual men in the US during 1978, and had not existed in the US prior to that time. Subsequently, a serological variant, HTV-2, was identified in West Africa 5 . HTV-2 leads to persistent life-long infection, and is also associated with the clinical development of AIDS, many years after infection. However, there are reproducible data which show that the likelihood of AIDS developing after HTV-2 infection are lower at 10 years post-infection than with HTV-1, and that HIV-2 is generally less pathogenic, and less transmissible, than HTV-1 6 . These epidemiological observations are matched by an apparent lower HTV-2 viral load in peripheral blood than seen in the corresponding time from infection in HIV-1 infected subjects 7 .
The full-length sequencing of HTV-1 and HIV-2 isolates revealed that these viruses were lentiviruses, of the retrovirus family, and that all isolates shared a common tropism for T-lymphocytes, through the use of the CD4 receptor*- 9 . The emergence of a new infectious agent in a human population can have only a limited range of explanation; either the infection was previously in an isolated human population from which it had been exported though some societal change, or else it might have been a zoonosis, newly exposed to human transmission. A third line of explanation, that of an extra-terrestrial or even a man-made origin, has been popular with conspiracy theorists, but will not be further discussed.
The natural history of HTV-1 infection is marked by the long period of time between infection and disease. Following infection across a genital surface, involving infection of CD4/CCR5 bearing cells in the mucosa or submucosa, the virus presumably migrates to a regional lymph node, where viral replication occurs 10 . A number of rounds of viral replication then occur within the bounds of the regional lymph node, as no detectable virus or immune response occurs for up to 42 days post infection. When the quantity of infected cells exceeds a threshold, viraemia occurs, and the symptoms of an acute non-specific viral illness with tender adenopathy, sore throat, diffuse macular rash, arthralgia and fever. Following the acute viraemia, when up to 10 7 viral particles/ml plasma can be found, a primary immune response develops with antibodies to viral proteins and a cytotoxic T-cell response, which limit viral replication and clear viral particles from the plasma. The reduction in viral load in plasma is not matched by a clearance of provirus from peripheral blood mononuclear cells, and cellular viraemia continues in the face of a persistent and sustained cellular and humoral immune response for the duration of the infection. Even while plasma viral load is suppressed by the immune response, CD4+ve T-lymphocyte numbers fall in a linear manner over time (see Fig. 1 ). The most plausible explanation for the pathogenesis of AIDS over time is the sustained loss of CD4 cells by ongoing HTV viral replication in mature peripheral blood T cells, and by a slight failure of production to match peripheral destruction of HTV+ve CD4+ve cells 1112 . However, recent controversy over the pathogenic mechanisms and homeostasis of T-cells has revealed that simple viral cytopathic effect on CD4+ve cells may be overly simplistic a model 13 . During the course of HTV infection, CD4+ve cells continue to decline in peripheral blood, and plasma viral load slowly rises; on average, CD4+ve cells are lost at a rate of 70 cells/ul/year. Over a period of 10-12 years, CD4 cell number declines from a median of 800 to 200/|xl; at this level, the probability of the cellular immune system containing latent or environmental infections such as P. carinii falls, and clinical opportunist infection becomes increasingly possible. As the viral load rises, HTV isolates with altered co-receptor usage appear, which can use the CXCR4 chemokine receptor rather than CCR5; these isolates are more cytopathic in vitro, and may lead to wider tissue distribution of HIV in later disease. AIDS is, therefore, the clinical condition of an immune system which is sufficiently compromised by HTV infection that there is an inability to protect against the growth of low grade pathogens or viral induced tumours.
The application of viral gene sequencing to the study of HTV-1 infection has been particularly informative. It was noted as early as 1985 that no two sequences of HTV-1 isolates were genetically identical 14 . HTV-1 isolates from patients in the US and in Zaire could differ by as much as 35% in their viral envelope (SU) amino-acid sequences. Even within an individual patient, multiple viral sequences could be obtained, and the swarm of related but separate viral genomes within a single host is termed a quasi-species. The SU protein of viruses within one individual may vary by up to 5% in amino acid sequence, although in phylogenetic analysis, these variants can be shown to be clearly related to a common ancestor viral sequence 15 . The causes of this extreme viral variability are the lack of proof reading in viral reverse transcription (RT), the error-prone RT enzyme which mis-incorporates at a rate of l:10 4 bases, and immune and receptor pressure exerted by the host, which allows for variants to compete for fitness 16 . On a population level, this potential for viral variability leads to the selection of viral variants upon transmission, resulting in global diversity of HTV strains. However, global sequence analyses reveal that the diversity can be grouped into related sequences, or viral subtypes. At least ten genetic subtypes of HTV-1 have now been described, termed HIV-1 subtypes A-J 17 , see Figure 2 . Of these groups, subtype B has been responsible for the pandemic of infection in homosexual men and i.v. drug users world-wide. All subtypes have been described in sub-Saharan Africa, but more limited subtypes account for new epidemic infections; for example, the heterosexual epidemic in south east Asia and Thailand is almost exclusively E subtype, and the C subtype accounts for most infections in southern Africa. As multiple infection can occur in one subject, at least prior to sero-conversion, recombination between subtypes is possible, and many chimaeric or recombinant viruses are now described. There are no convincing data at this time of any significant biological differences between the viral genetic subtypes, and they are not viral serotypes in the conventional use of the term. However, it is possible that variants will emerge which are more pathogenic or transmissible over time 18 .
Animal lentiviruses
It is now clear that lentiviruses are common causes of exogenous infections of mammalian hosts, generally maintained within the . Thus, there is a model for the development of human AIDS whereby a virus which is endemic and non-pathogenic in its 'natural' host (SIV sm ) may acquire a pathogenic phenotype on transmission to a non-natural host, the rhesus macaque. A non-pathogenic simian lentivirus might be anticipated to have a new phenotype if transmitted to man.
HIV-1 ENV WEIGHTED
Lentivirus infection can be extremely widespread within a single animal genus. For example, FIV infection can be identified by serological screening, and appears to infect up to 20% of domestic and household pet cats in the UK, US and Australia 20 . Similar rates of FIV infection have been reported in lions and cheetahs in the Serengeti reserve in Kenya/Tanzania, East Africa. This would imply that FTV infection of felines predates their speciation, approximately 20 million years ago. SIV infection of African green monkeys (AGM) is found at very high levels in wild caught populations, with population rates of up to 50% by serology. Unlike FTV infection, there is no evidence that SrV a infection leads to any discernible disease or immunosuppression in AGMs. There are three discrete sub-populations of African green monkeys in sub-Saharan Africa, termed vervet, grivet and sebaeus . Transmission of FTV appears to occur horizontally through biting and scratching between adults cats, with little evidence of sexual transmission, and by vertical transmission through breast milk predominantly. Similarly, natural transmission of SIV appears to be non-sexual between adults, and SIV appears to be maintained in the population largely through vertical transmission. Table 2 shows the grouping of primate lentiviruses into five subgroups: human isolates appear in two of these groups; the SFV group also contains the HTV-2 isolates, and the SFV group contains the HTV-1 isolates. The remaining three subgroups, representing SFV isolates from the mandrill (SIV m d ), the Sykes' monkey (SIV,. k ) and the African green monkey (SIV a ), do not appear to have any corresponding human isolates yet identified.
Few animal lentiviruses currently have defined cell surface virus receptors, with the notable exception of the SFV/HIV groups. All SIV and HTV isolates of all five groups bind primarily with high affinity to the CD4 molecule, and subsequently require a lower affinity interaction between the viral surface glycoprotein (SU) and a 7-transmembrane coreceptor molecule, the chemokine receptor CCR5 or CXCR4 21 . All primary human HTV infections appear to involve viruses which are CD4/CCR5 tropic, and the SIV isolates which can infect rhesus macaques appear to use the identical CD4/CCR5 receptor/co-receptors also. The FIV receptor is not feline CD4, but probably feline CD9; however, FTV appears to also use the CXCR4 co-receptor for entry. McClure has previously shown that the CD4 molecule is well conserved in humans, apes and monkeys, and this common receptor and co-receptor usage has allowed the entry of HFV-like viruses into human populations 22 .
Zoonotic origin of HIV
Of the five groups of primate lentiviruses, defined by phylogenetic analyses of viral gene sequences, shown in Table 2 , two groups contain viruses which can be found in both human and natural simian infections. This association of related viral sequences in both primate and man immediately lead to the likelihood of a zoonotic origin to the human infection. The potential zoonotic origins of HIV-1 and HTV-2 need to considered separately, and the information is considerably more partial for HIV-1 than HIV-2.
Origin of HIV-2
The most compelling data on the origins of HTV-2 come from the work of Hahn and colleagues (University of Alabama), in studying HIV-2 infections and SIV !m in Liberia. Through phylogenetic analyses on the SIV sm sequences from multiple unrelated wild caught animals, they were able to demonstrate a number of related but independent strains of SIV 23 . A similar phylogenetic analysis of human HTV-2 infections from a region overlapping the origin of the SFV strains revealed a similar distribution of strains, genetically related to the diversity of the SFV strains. From these data, Hahn argued for the interpretation of multiple entry of SFV^ into the human population as HTV-2, rather than a point source epidemic, and speculated that many human infections may have occurred separately over a long period of time. The near genetic identity of SFV sm and HTV-2 and the similar sub-type organisation of the two groups of viruses would support this hypothesis. The relatively low transmissibility of HTV-2, and its lower pathogenicity, have been responsible for the failure of HTV-2 to become epidemic in Africa, or pandemic. Indeed, although HTV-2 infection has been reported in India, South Africa, China, Europe and the US, there is little evidence of epidemic spread of HTV-2 from index cases in any of those countries.
Origins of HIV-1
The data on the possible zoonotic origins of HTV-1 are far less convincing than for HTV-2 and, to date, it has not been possible to identify a species convincingly infected in the wild with an HTV-1-like SFV virus. However, there have now been four independent isolations of an HIV-1 related SIV from wild caught chimpanzees, in the West Africa state of Gabon 24 . Despite these wholly plausible and reproducible isolations, serological surveys of chimpanzees have not revealed widespread infection of this species by SIV z , and the possibility of acquisition of infection in the chimpanzee through predation of another as yet unidentified species cannot be ruled out. By phylogenetic analysis, the SIV cpz is more closely related to HTV-1 than to HTV-2 or other SIV isolates; however, there is still a significant evolutionary distance between HIV-1 and the chimp SIV z sequences, suggesting that these SFVs cannot be the immediate origin of the human epidemic.
Additional insight into the evolutionary origins of HTV-1 have come from the global HIV genotyping initiative undertaken under the direction of the World Health Organization HIV Isolation and Characterisation Network. Phylogenetic analysis of sequences of HTV-1 isolates from diverse geographical locations have allowed the genetic subtypes of HIV-1 to be defined, into groups A-J; each subgroup contains viruses which may differ in up to 12-15% in amino-acid sequence, but the sequence differences between the subtypes exceed 25-30% (see Fig. 2 ). Each subtype seems to be equidistant from the others, in a star phylogeny in the rooted trees. There has been considerable investigation of the distribution of the genetic subtypes internationally. As noted above, the homosexual and IVDU epidemic from 1981 onwards was exclusively of subtype B, in the US, Europe, South Africa, Thailand and Australia. Subsequent heterosexual epidemics from 1990 onwards in South Africa and Thailand have been exclusively of subtypes C and E, respectively, representing new incoming subtypes rather than transmission from the previously infected endogenous groups. This implies that there was little sexual mixing between the earliest groups to be infected in these countries, for example homosexual white middle class men in South Africa infected in early 1980s with B subtype, and the subsequent epidemic of subtype C infection in black heterosexuals in the townships, mines and homelands. While groups have argued that subtypes C or E might be biologically advantageous to heterosexual transmission, through tropism for Langerhans cells in the vagina, for example, there is little consensus on the reproducibility of these findings, and it is equally plausible that the emergence of mono-subtype epidemics represents a founder effect rather than a biological tropism.
In sub-Saharan Africa, the finding of multiple HTV-1 genetic subtypes within a single risk group and geographical location is the norm. In Uganda, population based studies reveal HTV-1 subtypes A and D predominate, and co-exist within all parts of the country. In similar studies in Gabon and Cameroun, it is possible to identify all subtypes A-J through examination of randomly selected HTV-l+ve subjects attending clinics, and it appears that all subtypes are currently circulating and being transmitted in these countries. The countries with the greatest prevalence of diverse subtypes are Gabon, Cameroun, Central African Republic and Zaire, and the frequency of subtypes diminishes with distance from these countries, with the epidemic showing the greatest homogeneity in South Africa 18 . The current interpretation of these data is that the countries with the greatest genetic diversity are those in which the HTV-1 epidemic is oldest. There is a remarkable overlap between the distribution of the SIV z isolates, from Gabon, and those countries with the greatest frequency of divergent sequences, which include Gabon. Finally, in the course of a serological survey of sera from Cameroun from 1956, a partial HTV-1 viral sequence has been amplified by PCR; this ancestral HIV-1 sits close to the centre of the phylogenetic tree shown in Figure 2 , and is related to the B and D subtypes. Analysis of the divergence of sequence all suggest an origin of HTV-l in human populations of approximately 50 years 26 .
Origins of the HIV-1 pandemic
The evidence outlined above points to an origin of HTV-1 as a new human infection in the past 50 years, most likely as a zoonosis from a simian host in west/central Africa. There is no documented clinical, serological or virological evidence of HIV-1 occurring in human populations before the 1950s. The great diversity of HTV-1 sequences within the human population are compatible with a recent origin, although none of these pieces of evidence are conclusive. Nonetheless, it is worthwhile considering the rise of the HIV epidemic in the context of population movements and social change in sub-Saharan Africa since the second World War. This period has been marked by migration of large populations from low density rural environments to high density urban and peri-urban townships, shanties and towns. It is reasonable to hypothesise that HTV-1 infection, arising in humans from a zoonotic origin, may have occurred intermittently in rural areas in Gabon, where infected animals and humans may have frequently encountered one another. Infection of adults in areas of low social mobility might have lead to some horizontal transmission through sexual intercourse, but the infection would have required substantial vertical transmission from mother to child in order to be sustained within the population. In the case of HTV-2, low pathogenic potential leads to a long period of infectious carriage; however, the pathogenic nature of HFV-1 would lead to high mortality in infected adults. The low expectation of children infected at birth to survive to maturity would not allow significant vertically acquired infection to contribute to adult horizontal transmission. Only with the movement of populations to a peri-urban or urban environment, with greater potential from horizontal sexual transmission, could HTV-1 infection become epidemic.
Impact of sexually transmitted diseases
This movement of small numbers of HTV-1 infected adults to a more densely populated peri-urban area would allow for rapid dissemination of a sexually transmitted agent through the more extended sexual networks associated with urban life. The impact of untreated sexually transmitted diseases, such as syphilis, gonorrhoea and chancroid, in causing genital ulceration and facilitating the spread of HTV-1 is considerably higher in sub-Saharan Africa than elsewhere. Several studies have demonstrated the facilitating effect of genital ulcer disease on HTV transmission, presumably both by increasing HIV load in genital secretions through the presence of inflammatory cells including CD4+ve T-cells, and by facilitating transmission across a disrupted mucosal surface 27 . While there had been considerable opportunity for STDs to be controlled in Africa through population based diagnosis and treatment, even up to the present day there has been little investment in health care services for STDs. The failure to control STDs was not due to antibiotic resistance, nor to any emergent or resurgent organisms, but simply through lack of political will to invest in control measures.
Non-infectious factors in HIV transmission
The great social changes since 1945 do not only involve movement of populations from the rural to the urban environment, but also include technological changes of great impact. Parenteral access to the body via the use of re-useable and subsequently disposable hypodermic needles and syringes, the ability to undertake blood transfusion and widespread immunisation have had a major impact on the delivery of health care, and for the control of infectious disease. However, contamination of needles or blood has also acted to transit viral infection, and this mode of transmission has undoubtedly exacerbated the dissemination of HIV through populations. While there has been speculation that widespread immunisation may have directly lead to HTV transmission, and indeed might have been the cause of the epidemic, there are no data to suggest direct contamination of vaccine stocks in the 1950s, nor of any transmission of SIV via the African green monkey kidney cells used to propagate polio vaccine strains.
Comparison with endemic human retroviruses
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The HIV epidemic must be compared and contrasted to the epidemiology of the other human retrovirus, the human T-cell leukaemia/lymphoma virus, HTLV-I and HTLV-II. These oncornaviruses are endemic in old human populations, and are found in 2-5% of the population in West Africa, and in migrants from this region to North, Central and South America; in Japan and the eastern seaboard of Asia, in Melanesia and in Australian Aboriginals, and in Amerindians 28 . This distribution suggests human infection at least for 50 000 years. There is a related simian virus, STLV, which is found in both Asian and African old world monkeys, and presumably HTLV was initially a zoonosis, although the infection has been maintained in human populations through horizontal and vertical transmission. The infection is persistent and lifelong, but mortality is low, and morbidity uncommon until after the reproductive years, allowing a stable endemic infection to be established. However, population movements and social changes since 1945 are also leading to new epidemic dissemination of HTLV-I as a sexually transmitted infection in Europe, and to a global epidemic of HTLV-II in IVDUs. It is not yet clear whether the movement of HTLV into new populations will affect the clinical manifestations or frequency of pathology, as it is likely that the pathogenesis of the HTLV associated diseases have an immunogenetic basis. Thus new epidemic spread may not only lead to global distribution of a previously localised endemic disease, but may also affect disease manifestations.
